NKCFO LLC’s Guardant Health GH Stock Holding History

NKCFO LLC’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,500	Closed	-$107K	–	103
2025 Q1	$107K	Buy	+2,500	New	+$108K	0.05%	68

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

NKCFO LLC's GH Position: Q2 2025 in Review

NKCFO LLC sold out of Guardant Health (GH) in Q2 2025, closing a stake of 2,500 shares — an estimated $107K sold.

NKCFO LLC first reported a position in GH in Q1 2025 and held it in 1 quarter. The position peaked at $107K in Q1 2025. 365 funds tracked by Wall St. Rank hold GH as of Q2 2025.

NKCFO LLC reported no remaining Guardant Health position as of Q2 2025 after selling out during the quarter.
NKCFO LLC sold 2,500 Guardant Health shares in Q2 2025, an estimated $107K.
NKCFO LLC first reported a position in Guardant Health in Q1 2025 and held it in 1 quarter.
NKCFO LLC's Guardant Health position peaked at $107K in Q1 2025.
365 funds tracked by Wall St. Rank held Guardant Health as of Q2 2025.

Based on NKCFO LLC's 13F filing for Q2 2025, filed 13 Aug 2025.